Urgent.News

What's breaking now, across thousands of outlets.

More in Business

Danish BioTech Samplix secures €25 million in first close of financing round to scale antibody discovery

Samplix, a Danish BioTech company developing droplet microfluidics technology for functional single-cell analysis, has secured a €25 million first closing of its new financing round.

  • Danish biotech Samplix secures €25 million in first financing round
  • WLanholding GmbH leads investment with €3 million new capital
  • Xdrop platform used for antibody discovery and functional single-cell research

More from Wednesday 28 October →